Roundtables- Using Artificial Intelligence for In-Silico Radiopharmaceutical Drug Design to De-Risk Your Molecule
- Exploring screening through in-silico models
- Understanding what data it can bring
- Maximizing understandings for novel radiopharmaceuticals